
No data
No data
No data
| CAS Number | 74150-27-9 |
| Catalog Number | AG00FA4E(AGN-PC-0U4L3Y) |
| Chemical Name | Pimobendan |
| IUPAC Name | 3-[2-(4-methoxyphenyl)-3H-benzimidazol-5-yl]-4-methyl-4,5-dihydro-1H-pyridazin-6-one |
| InChI | InChI=1S/C19H18N4O2/c1-11-9-17(24)22-23-18(11)13-5-8-15-16(10-13)21-19(20-15)12-3-6-14(25-2)7-4-12/h3-8,10-11H,9H2,1-2H3,(H,20,21)(H,22,24) |
| InChI Key | GLBJJMFZWDBELO-UHFFFAOYSA-N |
| MDL Number | MFCD00761648 |
| Molecular Formula | C19H18N4O2 |
| Molecular Weight | 334.3718 |
| SMILES | O=C1CC(C)C(C2=CC=C3C(N=C(C4=CC=C(OC)C=C4)N3)=C2)=NN1 |
| Synonyms | 4,5-dihydro-6-(2-(4-methoxyphenyl)-1H-benzimidazole-5-yl)-5-methyl-3(2H)-pyridazinone,
pimobendan,
pimobendane,
UD CG 115,
UD-CG 115,
UD-CG115,
pimobendan,
74150-27-9,
pimobendane,
Acardi,
dl-Pimobendan,
Vetmedin,
Pimobendanum,
d-Pimobendan,
l-Pimobendan,
Racemic pinobendan,
UD-CG 115 BS,
(+)-Pimobendan,
(-)-Pimobendan,
UD-CG 115,
Pimobendan (Vetmedin),
Pimobendan [INN-Spanish],
Pimobendane [INN-French],
Pimobendanum [INN-Latin],
UNII-613JXV89SU,
UNII-9HTU209Z0N,
(+)-UD-CG 115BS,
(-)-UD-CG 115BS,
BRN 4207330,
CHEMBL24646,
UD-CG-115BS,
613JXV89SU,
9HTU209Z0N,
UDCG-115,
CHEBI:32003,
4,5-Dihydro-6-[2-(4-methoxyphenyl)-1H-benzimidazol-5-yl]-5-methyl-3(2H)-pyridazinone,
AK482253,
(+)-4,5-Dihydro-6-(2-(4-methoxyphenyl)-1H-benzimidazol-5-yl)-5-methyl-3(2H)-pyridazinone,
(-)-4,5-Dihydro-6-(2-(4-methoxyphenyl)-1H-benzimidazol-5-yl)-5-methyl-3(2H)-pyridazinone,
6-(2-(4-Methoxyphenyl)-4,5-dihydro-1H-benzimidazol-5-yl)-5-methyl-3(2H)-pyridazinone,
6-[2-(4-methoxyphenyl)-1H-benzimidazol-5-yl]-5-methyl-4,5-dihydropyridazin-3(2H)-one,
3(2H)-Pyridazinone, 4,5-dihydro-6-(2-(4-methoxyphenyl)-1H-benzimidazol-5-yl)-5-methyl-, (+)-,
3(2H)-Pyridazinone, 4,5-dihydro-6-(2-(4-methoxyphenyl)-1H-benzimidazol-5-yl)-5-methyl-, (-)-,
3(2H)-Pyridazinone, 4,5-dihydro-6-(2-(4-methoxyphenyl)-1H-benzimidazol-5-yl)-5-methyl-,
3-[2-(4-methoxyphenyl)-3H-benzimidazol-5-yl]-4-methyl-4,5-dihydro-1H-pyridazin-6-one,
6-(2-(4-methoxyphenyl)-1H-benzo[d]imidazol-6-yl)-5-methyl-4,5-dihydropyridazin-3(2H)-one,
6-[2-(4-Methoxy-phenyl)-1H-benzoimidazol-5-yl]-5-methyl-4,5-dihydro-2H-pyridazin-3-one,
6-(2-(4-METHOXYPHENYL)-1H-BENZO[D]IMIDAZOL-5-YL)-5-METHYL-4,5-DIHYDROPYRIDAZIN-3(2H)-ONE,
Pimobendan, (+)-,
Pimobendan, (-)-,
ud cg 115 bs,
NCGC00274063-01,
Pimobendan [USAN:INN],
Pimobendan [USAN:INN:BAN],
3-[2-(4-methoxyphenyl)-1H-benzimidazol-5-yl]-4-methyl-4,5-dihydro-1H-pyridazin-6-one,
(+-)-UD-CG 115BS,
Acardi (TN),
Pimobendan(Vetmedin),
Pimobendan - Vetmedin,
AC1Q6OY4,
SCHEMBL27623,
118428-37-8,
118428-38-9,
MLS006010188,
Pimobendan (JAN/USAN/INN),
AC1L1J18,
DTXSID8048280,
Pimobendan, >=98% (HPLC),
CTK5E4521,
KS-00000GXC,
UD-CG-115,
HMS3655I03,
KUC109647N,
BCP02958,
HY-B0204,
AC-689,
BDBM50282617,
MFCD00761648,
s1550,
AKOS015851937,
AKOS015967705,
AN-1099,
CS-2143,
KS-1280,
MCULE-4183495834,
RP18110,
(+-)-4,5-Dihydro-6-(2-(4-methoxyphenyl)-1H-benzimidazol-5-yl)-5-methyl-3(2H)-pyridazinone,
(+-)-4,5-Dihydro-6-(2-(p-methoxyphenyl)-5-benzimidazolyl)-5-methyl-3(2H)-pyridazinone,
KSC-210-009,
NCGC00274063-05,
118428-36-7,
BC226374,
CC-33793,
SC-19312,
SMR002530068,
BCP0726000255,
AB0008564,
AB1011451,
LS-129899,
LS-129900,
LS-129901,
LS-185069,
FT-0630830,
SW219717-1,
D01133,
Z-8899,
AB01274800-01,
AB01274800_02,
150P279,
I06-2191,
J-517984,
Pimobendan, United States Pharmacopeia (USP) Reference Standard,
4,5-dihydro-6-[2-(4-methoxy-phenyl)-1h-benzimidazol-5-yl]-5-methyl-3 (2h)-pyridazinone,
Pimobendan for system suitability, European Pharmacopoeia (EP) Reference Standard,
3(2H)-Pyridazinone, 4,5-dihydro-6-(2-(4-methoxyphenyl)-1H-benzimidazol-5-yl)-5-methyl-, (+-)-,
Pimobendan hydrochloride,
UNII-34AP3BBP9T,
34AP3BBP9T,
cc-586,
Pimobendan hydrochloride [MI],
UD-CG115,
UDCG 115,
UNII-7595Q8C89H,
UD CG 115,
CID4823,
C19H18N4O2,
Pimobendan hydrochloride, (+/-)-,
AR-1L7919,
C19-H18-N4-O2,
ACN-044343,
C041648,
4,5-Dihydro-6-[2- -1H-benzimidazol-5-yl]-5-methyl-3 -pyridazinone,
77469-98-8,
3(2H)-Pyridazinone, 4,5-dihydro-6-[2-(4-methoxyphenyl)-1H-benzimidazol-5-yl]-5-methyl-,
3(2H)-Pyridazinone,4,5-dihydro-6-[2-(4-methoxyphenyl)-1H-benzimidazol-6-yl]-5-methyl-,
4,5-dihydro-6-(2-(4-methoxyphenyl)-1H-benzimidazole-5-yl)-5-methyl-3(2H)-pyridazinone,
3(2H)-Pyridazinone, 4,5-dihydro-6-(2-(4-methoxyphenyl)-1H-benzimidazol-6-yl)-5-methyl-, hydrochloride (1:1),
77-57-6,
|
| Complexity | 530 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 334.143g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 25 |
| Hydrogen Bond Acceptor Count | 4 |
| Hydrogen Bond Donor Count | 2 |
| Isotope Atom Count | 0 |
| Molecular Weight | 334.379g/mol |
| Monoisotopic Mass | 334.143g/mol |
| Rotatable Bond Count | 3 |
| Topological Polar Surface Area | 79.4A^2 |
| Undefined Atom Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | 2.7 |
| Symbol: | |
| Hazard Class | 6.1 |
| Hazard statements | H302-H315-H319-H335 |
| Packing Group | Ⅲ |
| Precautionary statements | P280-P305+P351+P338 |
| UN Code | UN 2811 |
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
| Test: | Result: |

